Supplement to October 2011 (vol. 205, no. 4, page S21)

Jeffrey T. Jensen, MD, MPH, has supplied a conflict of interest statement to replace the “reports no conflict” statement published with his article in a supplement to the October 2011 issue of the Journal (A hormonal contraception update: a decade of innovation & transformation).

The following statement should have appeared with the article (The future of contraception: innovations in contraceptive agents: tomorrow’s hormonal contraceptive agents and their clinical implications. Am J Obstet Gynecol 2011;205:S21-5):

Dr Jensen is a consultant and speaker for Bayer HealthCare Pharmaceuticals Inc. and a consultant for Schering Plough (Merck), Agile Pharmaceuticals, and HRA Pharma. He has received research funding from Bayer HealthCare Pharmaceuticals Inc., Wyeth Pharmaceuticals, Warner Chilcott, the Population Council, and the National Institutes of Health.